Lanean...
Clinical Implications of “Tailored” Antiplatelet Therapy in Patients With Chronic Total Occlusion
BACKGROUND: Clopidogrel nonresponsiveness is a prognostic marker after percutaneous coronary intervention. Prasugrel and ticagrelor provide a better platelet inhibition and represent the first‐line antiplatelet treatment in acute coronary syndrome. We sought to assess the prognostic impact of high p...
Gorde:
| Argitaratua izan da: | J Am Heart Assoc |
|---|---|
| Egile Nagusiak: | , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7070214/ https://ncbi.nlm.nih.gov/pubmed/32067582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.014676 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|